• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶的活性位点。从与因子IXa、因子Xa和凝血酶形成的复合物中释放出相同的经蛋白水解切割的抑制剂形式。

The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.

作者信息

Björk I, Jackson C M, Jörnvall H, Lavine K K, Nordling K, Salsgiver W J

出版信息

J Biol Chem. 1982 Mar 10;257(5):2406-11.

PMID:6977539
Abstract

Reactions between near equimolar amounts of antithrombin and Factors IXa or Xa resulted in the formation of a free proteolytically modified, two-chain form of the inhibitor, in addition to the inactive antithrombin-protease complexes. The modified inhibitor produced by either enzyme was electrophoretically identical with that formed in the reaction with thrombin. As in the latter reaction, the formation of the modified antithrombin by Factor Xa was increased in the presence of heparin, while only small amounts were produced by Factor IXa both in the absence and presence of the polysaccharide. NH2-terminal sequence analyses of the isolated modified inhibitor formed by Factor Xa showed that a single Arg-Ser bond in the COOH-terminal end of the inhibitor had been cleaved. This cleavage site is identical with that identified in free thrombin-modified antithrombin. The purified antithrombin-Factor IXa and antithrombin-Factor Xa complexes were dissociated by ammonia or hydroxylamine into free enzyme and a modified two-chain form of the inhibitor. Electrophoresis studies and NH2-terminal sequence analyses showed that the modified antithrombin obtained from either complex was identical with that produced in free form by the two enzymes and also with the modified inhibitor that is released from the antithrombin-thrombin complex. The fact that identical results were obtained for the reactions between antithrombin and three enzymes with different specificities strongly suggests that the observed Arg-Ser cleavage site is the active site of antithrombin.

摘要

抗凝血酶与近等摩尔量的因子IXa或Xa之间的反应,除了形成无活性的抗凝血酶-蛋白酶复合物外,还导致形成一种游离的、经蛋白水解修饰的双链形式的抑制剂。由这两种酶产生的修饰抑制剂在电泳上与在与凝血酶反应中形成的抑制剂相同。与后一种反应一样,在肝素存在下,因子Xa形成修饰抗凝血酶的量增加,而无论有无多糖存在,因子IXa产生的修饰抗凝血酶量都很少。对因子Xa形成的分离修饰抑制剂进行的氨基末端序列分析表明,抑制剂羧基末端的一个精氨酸-丝氨酸键已被切割。这个切割位点与在游离凝血酶修饰的抗凝血酶中鉴定出的位点相同。纯化的抗凝血酶-因子IXa和抗凝血酶-因子Xa复合物被氨或羟胺解离成游离酶和修饰的双链形式的抑制剂。电泳研究和氨基末端序列分析表明,从任一复合物中获得的修饰抗凝血酶与两种酶以游离形式产生的修饰抗凝血酶相同,也与从抗凝血酶-凝血酶复合物中释放的修饰抑制剂相同。抗凝血酶与三种具有不同特异性的酶之间的反应得到相同结果,这一事实强烈表明观察到的精氨酸-丝氨酸切割位点是抗凝血酶的活性位点。

相似文献

1
The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.抗凝血酶的活性位点。从与因子IXa、因子Xa和凝血酶形成的复合物中释放出相同的经蛋白水解切割的抑制剂形式。
J Biol Chem. 1982 Mar 10;257(5):2406-11.
2
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.低分子量肝素存在下止血酶与抗凝血酶相互作用的动力学
J Biol Chem. 1980 Nov 10;255(21):10081-90.
3
Mechanism of inactivation of trypsin by antithrombin.抗凝血酶使胰蛋白酶失活的机制。
Biochem J. 1982 Oct 1;207(1):21-8. doi: 10.1042/bj2070021.
4
Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.肝素及类肝素分子在血栓形成和动脉粥样硬化中的作用。
Fed Proc. 1985 Feb;44(2):404-9.
5
A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.牛主动脉段上导致凝血因子Xa和凝血酶生成的凝血途径。
J Clin Invest. 1984 Dec;74(6):1910-21. doi: 10.1172/JCI111611.
6
Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.利用氨基酸和肽硫酯对牛凝血酶、因子IXa、因子Xa、因子XIa、因子XIIa、血浆激肽释放酶和胰蛋白酶的活性位点进行定位:新型敏感底物的开发
Biochemistry. 1981 Dec 8;20(25):7196-206. doi: 10.1021/bi00528a022.
7
Dissociation of complexes and their derivatives formed during inhibition of bovine thrombin and activated factor X by antithrombin III.抗凝血酶III抑制牛凝血酶和活化因子X过程中形成的复合物及其衍生物的解离。
J Biol Chem. 1979 Feb 25;254(4):1044-9.
8
Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.人及小鼠血浆中凝血因子IXa的体外调节以及小鼠体内的调节。内皮细胞和血浆蛋白酶抑制剂的作用。
J Clin Invest. 1984 Jun;73(6):1696-703. doi: 10.1172/JCI111377.
9
Immunological evidence for a proteolytic cleavage at the active site of antithrombin in the mechanism of inhibition of coagulation serine proteases.
Eur J Biochem. 1981 Jun 1;116(3):493-6. doi: 10.1111/j.1432-1033.1981.tb05363.x.
10
Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.牛凝血因子IXaβ、因子Xaβ和因子XIa对含有牛因子IX和因子X激活位点序列的荧光肽的反应性。
Biochemistry. 1983 Mar 1;22(5):1021-9. doi: 10.1021/bi00274a004.

引用本文的文献

1
Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.在携带393位精氨酸突变为组氨酸的抗凝血酶的河内患者中出现的脑软化/胶质增生、深静脉血栓形成和癌症,以及β-淀粉样前体蛋白(APP)对血栓形成和癌症的潜在影响。
AIMS Neurosci. 2022 Apr 21;9(2):175-215. doi: 10.3934/Neuroscience.2022010. eCollection 2022.
2
The anti-inflammatory action of Bothrops jararaca snake antithrombin on acute inflammation induced by carrageenan in mice.矛头蝮蛇抗凝血酶对卡拉胶诱导的小鼠急性炎症的抗炎作用。
Inflamm Res. 2013 Aug;62(8):733-42. doi: 10.1007/s00011-013-0628-x. Epub 2013 May 12.
3
Three pairs of protease-serpin complexes cooperatively regulate the insect innate immune responses.
三对蛋白酶-丝氨酸蛋白酶抑制剂复合物协同调控昆虫先天免疫反应。
J Biol Chem. 2009 Dec 18;284(51):35652-8. doi: 10.1074/jbc.M109.071001.
4
Antithrombin III: summary of first database update.抗凝血酶III:首个数据库更新总结
Nucleic Acids Res. 1994 Sep;22(17):3556-9.
5
Chemotactic response of monocytes to thrombin.单核细胞对凝血酶的趋化反应。
J Cell Biol. 1983 Jan;96(1):282-5. doi: 10.1083/jcb.96.1.282.
6
Mechanism of inactivation of trypsin by antithrombin.抗凝血酶使胰蛋白酶失活的机制。
Biochem J. 1982 Oct 1;207(1):21-8. doi: 10.1042/bj2070021.
7
Mechanism of the anticoagulant action of heparin.肝素抗凝作用的机制。
Mol Cell Biochem. 1982 Oct 29;48(3):161-82. doi: 10.1007/BF00421226.
8
Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.在有肝素和无肝素情况下形成的抗凝血酶 - 凝血酶复合物的特性。
Biochem J. 1983 Aug 1;213(2):345-53. doi: 10.1042/bj2130345.
9
Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.富山抗凝血酶III:遗传性异常抗凝血酶III中精氨酸-47被半胱氨酸取代,该抗凝血酶III缺乏肝素结合能力。
Proc Natl Acad Sci U S A. 1984 Jan;81(2):289-93. doi: 10.1073/pnas.81.2.289.
10
Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.
Proc Natl Acad Sci U S A. 1983 Nov;80(22):6804-8. doi: 10.1073/pnas.80.22.6804.